Abstract Aim The “2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure”
replaces the “2013 ACCF/AHA Guideline for the Management of Heart Failure” and the …

Takotsubo cardiomyopathy (TTS) has become a recognised clinical entity since the
Japanese scientist Sato first described it in 1990. Despite an increasing number of …

ABSTRACT Aim The “2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure”
replaces the “2013 ACCF/AHA Guideline for the Management of Heart Failure” and the …

ABSTRACT AIM The “2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure”
replaces the “2013 ACCF/AHA Guideline for the Management of Heart Failure” and the …

Background—Stress cardiomyopathy (SCM) is a peculiar form of reversible left ventricular
dysfunction seen predominantly in women and occurs in response to emotional or physical …

Simple Summary Immune checkpoint inhibitors (ICIs) are novel cancer therapeutics that
address the immune system to attack malignancies. While this therapy has significantly …

Background Cardiogenic shock occurs in 10%–15% of patients with Takotsubo syndrome
(TS). For several reasons catecholamines, and especially inotropes, should be avoided in …

Takotsubo cardiomyopathy (TTC), a persistently obscure dysfunctional condition of the left
ventricle, is uniquely transient but nevertheless dangerous. It features variable ventricular …

Objectives To analyze the characteristics and outcome of Impella mechanical circulatory
support (MCS) for Takotsubo syndrome (TS) with cardiogenic shock. Background TS is an …

Takotsubo cardiomyopathy. Literature review: concept, epidemiology, pathogenesis. Part I |
Boldueva | Russian Journal of Cardiology Russian Journal of Cardiology eng | рус User …